Advertisement

Topics

Latest "Integrated Genomics, Inc." News Stories

00:08 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Integrated Genomics, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Integrated Genomics, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Integrated Genomics, Inc. for you to read. Along with our medical data and news we also list Integrated Genomics, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Integrated Genomics, Inc. Companies for you to search.

Showing "Integrated Genomics" News Articles 1–25 of 3,300+

Monday 25th March 2019

Widex USA to Showcase Its Latest Technology at AAA Booth #1025 – March 27-29, 2019

Visitors to Demo Widex ENERGY CELL™ Technology and Get a Live Hearing Demo of Second Generation Widex EVOKE™ Widex USA, Inc. will be exhibiting at the 20


Research Suggests New Drug Targets for Osteoporosis

NewsScientists have harnessed powerful data analysis tools and three-dimensional studies of genomic geography to implicate new risk genes for osteoporosis.

DATA: Global Device Approvals Snapshot: March 18 – March 25, 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week FDA...   


Netsmart Implements Industry-First Interoperability 360X Standards to Support Transparency Between Healthcare Providers

Netsmart has announced plans to release industry-first interoperability standards to improve communication between primary care and community-based healthcare providers. The new standards are designed to improve referral management, close communication gaps and enable transparency between care settings. The healthcare IT

MJIC Announces Name Change to ManifestSeven

Cannabis industry’s leading omnichannel distribution & retail superhighway prepares for public listing; Signifies the company’s evolution towards its next phase of growth MJIC, Inc. (“MJIC” or the “Company”), a fully integrated omnichannel platform for legal cannabis, today announced that the Company will change its name to Man...

Genetesis secures FDA 510(k) clearance for cardiac imaging platform

Genetesis said that its cardiac imaging platform works by pairing the CardioFlux Magnetocardiograph with the integrated Faraday Analytical Cloud (FAC). CardioFlux technology allows simple, rapid, non-invasive cardiac imaging. The post Genetesis secures FDA 510(k) clearance for cardiac imaging platform appeared first on Compelo Medical Devices - Latest industry news and analysis.

Philips, Delta Dental of California partner to advance oral health and improve healthcare outcomes

The companies plan to lend their respective expertise and conduct research in a joint effort to build integrated insurance and oral hygiene and wellness solutions within an evolving The post Philips, Delta Dental of California partner to advance oral health and improve healthcare outcomes appeared first on Compelo Medical Devices - Latest industry news and analysis.

SEQENS North America Wins Big at 2019 Life Science Leader Magazine CMO Leadership Awards

Wins “Top Performer” in 12 categories SEQENS North America (formerly PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, announced that it has won six additional 2019 Life Science Leader CMO Leadership Awards that...

Hoy Health Launches Free HoyMEDS® Medication Discount Mobile App: Discounts on Costly Prescription Medications for Anyone, Anywhere in the U.S. and Puerto Rico

Visit Apple’s App Store or Google Play to download for FREE today!

Netsmart Delivers More for Whole-Person Care at NatCon19

Netsmart will showcase how organizations are leading the journey to make whole-person care a reality at the nation’s largest behavioral health conference, National Council for Behavioral Health’s

Turning Point Therapeutics Appoints Jim Mazzola to Lead Corporate Communication and Investor Relations

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today the appointment of Jim Mazzola to lead corporate communication and investor relations, reporting to Chief Executive Officer Athena Countouriotis, M.D. "Jim joins at a pivotal ...

NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK’s Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy

Completion of Phase 1 First-in-Human Trials of Cryopreserved, Off-The-Shelf haNK Cells Leads the Way to Pivotal Phase 2 Trials in Relapsed Merkel Cell Carcinoma Funding to Support INDs for First-in-Human Targeted Off-The-Shelf NK Cells (t-haNKs) with PD-L1 and CD-19 as Tumor Targets

H3 Biomedicine Announces Multiple Presentations at Upcoming AACR Annual Meeting

--Presentations highlight company’s expertise seamlessly integrating human biology, data science and modern chemistry to advance a pipeline of investigational breakthrough precision oncology medicines-- H3 Biomedicine Inc., a U.S.-based precision medicine research & development subsidiary of Eisai Co., Ltd., today announced multiple presentations...

New Cigna Research Reveals Many Americans Are More Stressed, Less Rested and Spending Less Time with Family and Friends

Cigna supports whole person health as key to addressing loneliness and improving overall well-being in America Global health service company Cigna released results of its annual global 360 well-being survey, Well and Beyond, which found that America is the ninth ranked country for health and well-being. Well and Beyond findings also reveal that ...

Horizon Discovery to collaborate with St George’s University Hospital and EMQN to develop reference material for non-invasive prenatal testing

Cambridge, UK, 25 March 2019: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced it is collaborating with St George’s University Hospital, London, and the European Molecular Genetics Quality Network (EMQN), based within the Manchester Centre for Genomic Medicine at...

Integrated Dermatology Enters New York

Christine Finnin, M.D. Joins Integrated Dermatology in Latham, N.Y. Integrated Dermatology, the largest independent dermatology practice in the United States, is opening its first location in New York with the addition of Latham Dermatology. Dr. Christine Finnin will lead the medical team at Latham Dermatology as a full-time clinician and medical direc...

Goodman Magic Mile Charity Ramp Run 2019 raises over HK$1.27 million for The Fred Hollows Foundation to help reduce blindness

HONG KONG, March 25, 2019 /PRNewswire/ -- Goodman Group and its partner sponsors are greatly contributing to reducing blindness in rural China by raising over HK$1.27 million for The Fred Hollows Foundation at the  8th Goodman Interlink Magic Mile Charity Ramp Run held on March 24. More than 650 participants took part in a variety of races up the 15-floor cargo ramp at the flagship Goodman ...

Aino Health AB (publ): Aino Health hosts a seminar on value-based leadership

    25th March, 2019 Aino Health is hosting the INSEAD seminar "Value-Based Leadership and Business as a Force for Good" on 27 March. The seminar will explore "Fair Process Leadership," an approach to leadership that emphasizes high levels of transparency and openness towards a company's stakeholders. Ludo van der Heyden, professor at INSEAD, and Britta ...

Taking Cannabis on the Road; New Products and Management; (OTCQX: $HRVSF) (OTCQX: $MDCL) (CSE: $POT.C) (TSXV: $KHRN.V)

Point Roberts, WA and Delta, BC - March 25, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how companies are expanding their footprint and vertical integrated operations.

Sunday 24th March 2019

EASI Genomics: A project to provide free-of-charge access to sequencing technologies

(Center for Genomic Regulation) It was launched in February 2019 and opens its 1st call for proposals today. Sixteen project partners gathered last February to kick-off EASI Genomics, a new European funded project to provide easy access to sequencing technologies and analysis to researchers. EASI-Genomics also aims at building a community of practice which leverages advanced sequencing technologie...

Saturday 23rd March 2019

News digest – hot tea, cancer doctor shortages, junk food ad ban proposals and baby Grady  

Science blog Hot tea headlines miss crucial details Hot drinks hit the headlines this week after a study sparked claims that hot

Friday 22nd March 2019

American Oncology Network, LLC (AON) Introduces Specialty Oral Oncolytic Pharmacy

Community Oncology Patients Benefit from AON In-House Pharmacy Services The American Oncology Network, LLC (AON), an alliance of physicians and seasoned healthcare leaders, provides a unique array of support services to its affiliated community-based oncology practices, including in-house specialty pharmacy services. The AON Pharmacy streamlines the pr...

WuXi AppTec Reports Strong 2018 Annual Results

Revenue RMB9,614 Million, up 23.8% (25.4% at Constant Exchange Rate) Year-Over-Year Net Profit Attributable to Owners of the Company RMB2,261 Million, up 84.2% Year-Over-Year Diluted EPS RMB 2.21, up 70.0% Year-Over-Year SHANGHAI, March 22, 2019 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 0235...

Genomics England signs immunotherapy partnership with CCG

NHS England spin-out Genomics England and artificial intelligence (AI)-focused Cambridge Cancer Genomics (CCG) have announced they have entered into an...Read More... The post Genomics England signs immunotherapy partnership with CCG appeared first on Pharmaceutical Technology.

Cerveau Technologies Inc. Signs Research Agreement with Eisai Inc., for Novel Tau Imaging Agent

Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks